BRPI0912074A2 - composto e composição farmacêutica - Google Patents
composto e composição farmacêuticaInfo
- Publication number
- BRPI0912074A2 BRPI0912074A2 BRPI0912074A BRPI0912074A2 BR PI0912074 A2 BRPI0912074 A2 BR PI0912074A2 BR PI0912074 A BRPI0912074 A BR PI0912074A BR PI0912074 A2 BRPI0912074 A2 BR PI0912074A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Agronomy & Crop Science (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Environmental Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13610608P | 2008-08-12 | 2008-08-12 | |
| US61/136,106 | 2008-08-12 | ||
| PCT/US2009/004557 WO2010019203A1 (en) | 2008-08-12 | 2009-08-07 | Antifungal agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0912074A2 true BRPI0912074A2 (pt) | 2018-10-02 |
| BRPI0912074B1 BRPI0912074B1 (pt) | 2021-08-03 |
Family
ID=41669132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0912074-2A BRPI0912074B1 (pt) | 2008-08-12 | 2009-08-07 | Composto e composição farmacêutica |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP2326172B1 (pt) |
| KR (1) | KR101686075B1 (pt) |
| AR (1) | AR073037A1 (pt) |
| BR (1) | BRPI0912074B1 (pt) |
| CL (1) | CL2011000292A1 (pt) |
| CO (1) | CO6351686A2 (pt) |
| CR (1) | CR20110075A (pt) |
| DK (1) | DK2326172T3 (pt) |
| DO (1) | DOP2011000053A (pt) |
| EA (1) | EA018337B1 (pt) |
| ES (1) | ES2526652T3 (pt) |
| GT (1) | GT201100039A (pt) |
| HN (1) | HN2011000404A (pt) |
| HR (1) | HRP20150009T1 (pt) |
| IL (2) | IL210975A (pt) |
| MA (1) | MA32628B1 (pt) |
| MX (1) | MX2011001656A (pt) |
| MY (1) | MY156955A (pt) |
| NI (1) | NI201100035A (pt) |
| NZ (1) | NZ590914A (pt) |
| PE (1) | PE20110676A1 (pt) |
| PL (1) | PL2326172T3 (pt) |
| PT (1) | PT2326172E (pt) |
| RS (1) | RS53731B1 (pt) |
| SI (1) | SI2326172T1 (pt) |
| SV (1) | SV2011003839A (pt) |
| TW (1) | TWI439458B (pt) |
| UA (1) | UA105639C2 (pt) |
| WO (1) | WO2010019203A1 (pt) |
| ZA (1) | ZA201100788B (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT3247711T (lt) | 2015-01-19 | 2022-05-25 | Scynexis, Inc. | Naujos scy-078 druskos ir polimorfai |
| EP3609539A1 (en) * | 2017-04-10 | 2020-02-19 | Scynexis, Inc. | Antifungal agents used in combination |
| EP4732902A2 (en) * | 2017-08-04 | 2026-04-29 | Scynexis, Inc. | Antifungal agents with enhanced activity in acidic ph |
| MA54866A (fr) * | 2019-01-30 | 2022-05-04 | Scynexis Inc | Antifongiques triterpénoïdes pour le traitement d'infections ostéoarticulaires fongiques |
| BR112021022876A2 (pt) * | 2019-05-16 | 2022-04-12 | Scynexis Inc | Método para descolonizar candida auris de uma área anatômica de um sujeito |
| EP4157356A1 (en) | 2020-05-29 | 2023-04-05 | Centre National de la Recherche Scientifique | Antifungal prodrugs |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997027860A1 (en) * | 1996-01-31 | 1997-08-07 | Merck & Co., Inc. | Antifungal agent |
| US5756472A (en) | 1996-01-31 | 1998-05-26 | Merck & Co., Inc. | Antifungal agent obtained from hormonema |
| CN1705657A (zh) * | 2002-04-17 | 2005-12-07 | 兰贝克赛实验室有限公司 | 作为抗真菌剂的吡咯衍生物 |
| DK2007396T3 (da) | 2006-04-03 | 2013-03-18 | Merck Sharp & Dohme | Enfumafungin-derivat som antimykotika |
-
2009
- 2009-08-07 RS RS20150006A patent/RS53731B1/sr unknown
- 2009-08-07 MY MYPI2011000483A patent/MY156955A/en unknown
- 2009-08-07 WO PCT/US2009/004557 patent/WO2010019203A1/en not_active Ceased
- 2009-08-07 PE PE2011000156A patent/PE20110676A1/es active IP Right Grant
- 2009-08-07 UA UAA201102860A patent/UA105639C2/uk unknown
- 2009-08-07 EA EA201100350A patent/EA018337B1/ru unknown
- 2009-08-07 BR BRPI0912074-2A patent/BRPI0912074B1/pt active IP Right Grant
- 2009-08-07 HR HRP20150009AT patent/HRP20150009T1/hr unknown
- 2009-08-07 SI SI200931102T patent/SI2326172T1/sl unknown
- 2009-08-07 NZ NZ590914A patent/NZ590914A/en unknown
- 2009-08-07 DK DK09806944.6T patent/DK2326172T3/da active
- 2009-08-07 PT PT98069446T patent/PT2326172E/pt unknown
- 2009-08-07 EP EP09806944.6A patent/EP2326172B1/en active Active
- 2009-08-07 KR KR1020117005837A patent/KR101686075B1/ko active Active
- 2009-08-07 ES ES09806944.6T patent/ES2526652T3/es active Active
- 2009-08-07 MX MX2011001656A patent/MX2011001656A/es active IP Right Grant
- 2009-08-07 PL PL09806944T patent/PL2326172T3/pl unknown
- 2009-08-10 TW TW098126822A patent/TWI439458B/zh active
- 2009-08-12 AR ARP090103123A patent/AR073037A1/es active IP Right Grant
-
2011
- 2011-01-31 ZA ZA2011/00788A patent/ZA201100788B/en unknown
- 2011-01-31 IL IL210975A patent/IL210975A/en active IP Right Grant
- 2011-02-08 CR CR20110075A patent/CR20110075A/es unknown
- 2011-02-10 NI NI201100035A patent/NI201100035A/es unknown
- 2011-02-11 CO CO11016262A patent/CO6351686A2/es active IP Right Grant
- 2011-02-11 CL CL2011000292A patent/CL2011000292A1/es unknown
- 2011-02-11 GT GT201100039A patent/GT201100039A/es unknown
- 2011-02-11 HN HN2011000404A patent/HN2011000404A/es unknown
- 2011-02-11 DO DO2011000053A patent/DOP2011000053A/es unknown
- 2011-02-11 SV SV2011003839A patent/SV2011003839A/es active IP Right Grant
- 2011-03-11 MA MA33691A patent/MA32628B1/fr unknown
-
2015
- 2015-10-12 IL IL242031A patent/IL242031A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2018014I1 (lt) | Farmacinė kompozicija 514 | |
| LTC2140867I2 (lt) | Farmacinė kompozicija | |
| BRPI0906962A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0906556A2 (pt) | Composto, e, composição farmacêutica | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| BRPI0917681A2 (pt) | Composto, e, composição farmacêutica | |
| EP2240022A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| BRPI0715712A2 (pt) | Composição farmacêutica | |
| BRPI0719393A2 (pt) | Composição farmacêutica | |
| DK3492069T3 (da) | Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid | |
| BRPI0920521A2 (pt) | combinação farmacêutica | |
| EP2373681A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| BRPI0905715A2 (pt) | Composição farmacêutica e kit de componentes | |
| IT1392101B1 (it) | Composizione comprendente isoflavoni | |
| DK2285413T3 (da) | Farmaceutisk sammensætning | |
| DK2285357T3 (da) | Farmaceutisk sammensætning omfattende brivaracetam | |
| BRPI0819232A2 (pt) | composto heterocíclico e composição farmacêutica do mesmo | |
| BRPI0908132A2 (pt) | Composto de benzodiazepina e composição farmacêutica | |
| EP2236149A4 (en) | MEDICAL COMPOSITION | |
| BRPI0720234A2 (pt) | Composição farmacêutica | |
| BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
| BRPI0921313A2 (pt) | composição farmaucêutica | |
| PT2209464E (pt) | Composição farmacêutica antimalárica | |
| BRPI0922286A2 (pt) | composto de quinolona e composição farmacêutica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/08/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |